| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/20/1999 | EP0642352B1 TRUNCATED TISSUE FACTOR AND FVIIa OR FVII ACTIVATOR FOR BLOOD COAGULATION |
| 01/20/1999 | EP0613496B1 Collagen-like polypeptides |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205708A Method of mobilizing hematopoietic stem cells |
| 01/20/1999 | CN1205703A Polymorphic foams of growth hormone secretagogue |
| 01/20/1999 | CN1205642A Sugar chain-recognizing antibody and remedy for infection with HIV |
| 01/20/1999 | CN1205628A Method and prepns. for stabilizing biological materials by drying methods without freezing |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205361A Disinfect peptide-X gene structure, prodn. tech. and use |
| 01/19/1999 | US5861502 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen |
| 01/19/1999 | US5861501 Capped synthetic RNA, analogs, and aptamers |
| 01/19/1999 | US5861499 Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861495 Human zinc binding proteins |
| 01/19/1999 | US5861494 Utilizing polynucleotides or polypeptides as a diagnostic marker for colon cancer |
| 01/19/1999 | US5861490 Cd8 suppressor molecule, fractionation of media and identification of fractions |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861485 Polypeptides involved in body weight disorders, including obesity |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861481 Peptide lung surfactants and therapeutic combinations |
| 01/19/1999 | US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity |
| 01/19/1999 | US5861478 Lytic peptides |
| 01/19/1999 | US5861476 Peptides and compounds that bind to the IL-1 receptor |
| 01/19/1999 | US5861475 Compositions and methods for the inhibition of phagocytes |
| 01/19/1999 | US5861438 Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists |
| 01/19/1999 | US5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 01/19/1999 | US5861406 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 01/19/1999 | US5861393 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 01/19/1999 | US5861386 Prevention of loss of bone mass or bone minerals |
| 01/19/1999 | US5861384 Suppression of rejection after transplants for organs orally in an amount in the range of about 5 to 2000 mg. |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861380 Oxadiazole, thiadiazole and triazole peptoids as inhibitors of human neutrophil elastase; adult respiratory distress syndrome; antiarthritic,-inflammatory,-ischemic,-tumor and -carcinogenic agents and other hne-mediated conditions |
| 01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861375 Compounds for treatment of malaria, toxoplasmosis and coccidiosis |
| 01/19/1999 | US5861374 Modified Factor VII |
| 01/19/1999 | US5861373 IGF-1 to improve the neural condition |
| 01/19/1999 | US5861372 Treatment of cancer, arthritis, macular degeneration and diabetic retinopathy |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861310 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861298 Cathepsin K gene |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861283 DNA encoding a limbic system-associated membrane protein |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861278 HNF3δ compositions |
| 01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
| 01/19/1999 | US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor |
| 01/19/1999 | US5861266 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861241 Monoclonal antibodies for detecting Norwalk virus |
| 01/19/1999 | US5861240 Isolated human herpesvirus type 8 sequences and uses thereof |
| 01/19/1999 | US5861239 Treating cells having tub genes(body weight controllers) with test compounds to determine if they change the reactions of the tub protein; drug screening, obesity therapy |
| 01/19/1999 | US5861238 Methods for partitioning advanced glycosylation endproducts |
| 01/19/1999 | US5861177 Spherical pancreatin particles free from added binder, free of 30-50 micrometer diameter particles; retain activity, made by treating before solvents are removed |
| 01/19/1999 | US5861176 Mixing alkoxides of silicon, calcium and phosphorous with an acid and active material(antibiotics, growth factors or enzyme inhibitors) then gelation, aging and drying yields porous glass matrix for healing or repairing bone defects |
| 01/19/1999 | US5861174 Temperature sensitive gel for sustained delivery of protein drugs |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861168 Vessels suffering vascular injury from angioplasty are treated with arginine or lysine to reduce probabilty of restenosis |
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/19/1999 | US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861154 Antitumor agents |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | US5861150 Recombinant human CSF-1 dimer and compositions thereof |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation |
| 01/19/1999 | CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases |
| 01/19/1999 | CA2108455C Pharmaceutical compositions against gastric disorders |
| 01/19/1999 | CA2089820C Treatment of tumorigenic pathophysiological conditions with fgf-cytotoxic conjugates |
| 01/19/1999 | CA2081703C Thrombin and method of producing the same |
| 01/19/1999 | CA2025900C Derivative of tissue-type plasminogen activator |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237147A1 Novel ratb |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237049A1 Novel ratc |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/17/1999 | CA2237162A1 Novel glucose kinase |
| 01/17/1999 | CA2237047A1 Novel xanthine phosphoribosyl transferase |
| 01/17/1999 | CA2237045A1 Novel glycogen phosphorylase |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001582A1 Screening methods using an atpase protein from a virus of the flaviviridae family |
| 01/14/1999 | WO1999001560A1 Vertebrate telomerase genes and proteins and uses thereof |
| 01/14/1999 | WO1999001557A1 Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001555A1 Genes for niemann-pick type c disease |
| 01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |